ODM-201 Inhibitor for Prostate Cancer
Neal D. Shore, MD, FACS discusses the androgen receptor inhibitor ODM-201 for castration-resistant prostate cancer.



New Biomarkers in Prostate Cancer
By E. David Crawford, MD, Karen Ventii, PhD, and Neal D. Shore, MD



Current Treatment Options for Metastatic, Castrate-Resistant Prostate Cancer



Clinical Investigators
D. Neal Shore
Neal D. Shore, MD, FACS

Medical Director, CPI (Certified Physician Investigator by the Association of Clinical Research Professionals)
Managing Partner, Atlantic Urology Clinics

Dr. Shore, serves as Medical Director for the Carolina Urologic Research Center and is the managing partner for Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr. Shore has conducted more than 150 clinical trials, focusing mainly on prostate and bladder disease, and serves on the boards of several academic and advocacy networks including the Society of Urologic Oncology Board of Directors, the Society Urologic Oncology Clinical Trials Consortium, the Large Urology Group Practice Association, NCI GU Science Steering Committee and the Urology Times. He has contributed to numerous peer-reviewed journals and has lectured extensively on the treatment of prostate and bladder cancers. A graduate of Duke University Medical School, Dr. Shore completed a 6 month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center, with a 6-month surgical rotation at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.
   
Dr. William Bogache
William Bogache, MD, FACS

Dr. Bogache received his undergraduate degree from the University of North Carolina, Chapel Hill and his medical degree from the Medical University of South Carolina in 1983. He completed his residency in General and Urologic Surgery at the Emory University Affiliated Hospitals in Atlanta, Georgia. He has served as Chief of Surgery, Chief of Staff and Chairman of the Board of Trustees at the Grand Strand Regional Medical Center and is currently the Medical Director of Parkway Surgery Center. He has a special interest in prostate diseases, incontinence, erectile dysfunction, stone disease and minimally invasive urologic procedures.
   
Kenneth E. Krzyzaniak
Kenneth E. Krzyzaniak, MD, FACS

CPI (Certified Physician Investigator by the Association of Clinical Research Professionals)

Dr. Krzyzaniak received his Bachelor of Arts degree and his MD degree from Indiana University. He completed a six-year residency at The University of Kentucky which included Internship, General Surgery, Clinical Research, Renal Transplant, and Urologic Surgery. He moved to South Carolina in 1981 and spent three years at The University of South Carolina School of Medicine as an Assistant Professor of Surgery. He was also Chief of Urology at the Dorn VA Medical Center in Columbia, S.C., where he taught both medical students and residents. Dr. Krzyzaniak has served as Chief of Surgery at Grand Strand Regional Medical Center, President of the Horry County Medical Society, President of The S.C. Urologic Association, and served four years on the Board of the Southeast Section of the American Urologic Association. Dr. Krzyzaniak is Board Certified, a Fellow of the American College of Surgeons, and maintains membership in numerous organizations including the American Urologic Association, SC Urologic Association, SC Medical Association, and American Association of Clinical Urologists. He has been involved in community service and is past president of Surfside Rotary. Dr. Krzyzaniak continues to have a strong interest in clinical research and is a certified Clinical Investigator.
   
Dr. Brian Roberts
Brian Roberts, MD, FACS

CPI (Certified Physician Investigator by the Association of Clinical Research Professionals)

Dr Roberts received his undergraduate and medical degrees from The University of Virginia. He completed a six year Urology residency at Georgetown University, where he won awards for his research in the field of prostate cancer. He has been practicing in Myrtle Beach, SC since 1998. He is Board Certified by the American Board of Urology and is a Fellow of the American College of Surgeons. He is active in numerous clinical research trials and is certified by the Association of Clinical Research Professionals as a Certified Clinical Investigator.  Dr Roberts areas of special interest include urologic oncology, minimally invasive and robotic surgery, female pelvic reconstruction, urinary dysfunction, and stone disease.
   
Dr. Richard Young
Richard Young, MD, FACS

Dr. Young received his under-graduate degree from Washington and Lee University in 1983 and his medical degree in 1987 from the Georgetown University School of Medicine in Washington, D.C. He completed a six year residency in General Surgery and Urology at Georgetown University in Washington, D.C. He is currently vice-chairman of the Surgical Performance Review Committee. He is a Fellow of the American College of Surgeons.
   
   
facebooktwitter
Studio303